Flex Ltd. Work in process decreased by 13.8% to $462.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.6%, from $465.00M to $462.00M. Over 4 years (FY 2021 to FY 2025), Work in process shows relatively stable performance with a 1.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $454.00M | $466.00M | $546.00M | $602.00M | $658.00M | $737.00M | $689.00M | $709.00M | $756.00M | $707.00M | $697.00M | $623.00M | $516.00M | $460.00M | $465.00M | $485.00M | $516.00M | $536.00M | $462.00M |
| QoQ Change | — | +2.6% | +17.2% | +10.3% | +9.3% | +12.0% | -6.5% | +2.9% | +6.6% | -6.5% | -1.4% | -10.6% | -17.2% | -10.9% | +1.1% | +4.3% | +6.4% | +3.9% | -13.8% |
| YoY Change | — | — | — | — | +44.9% | +58.2% | +26.2% | +17.8% | +14.9% | -4.1% | +1.2% | -12.1% | -31.7% | -34.9% | -33.3% | -22.2% | +0.0% | +16.5% | -0.6% |
| % of Inventories | 10.2% | 9.0% | 9.2% | 9.1% | 9.1% | 9.5% | 8.8% | 9.4% | 10.0% | 9.9% | 10.2% | 10.0% | 8.8% | 8.4% | 8.8% | 9.6% | 9.9% | 10.2% | 8.3% |
| Share Change | — | -1.2pp | +0.1pp | -0.0pp | -0.1pp | +0.5pp | -0.7pp | +0.6pp | +0.6pp | -0.2pp | +0.4pp | -0.2pp | -1.2pp | -0.4pp | +0.4pp | +0.7pp | +0.3pp | +0.3pp | -1.8pp |